These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8516833)

  • 21. Mechanism of prolonged allograft survival induced by ultraviolet B irradiated donor-specific blood transfusions and cyclosporine.
    Oluwole SF; Reemtsma K; Hardy MA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1097-101. PubMed ID: 2968697
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of immunosuppression by serum from liver grafted rats: evidence for functional clonal deletion in vivo.
    Kamada N; Yamaguchi A; Yoshimura S; Sumimoto R; Teramoto K; Baquerizo A
    Transplant Proc; 1990 Aug; 22(4):1971-2. PubMed ID: 2389501
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolongation of rat renal allograft survival by the synergistic effects of azathioprine and cholera toxin.
    Asano T; Murai M; Nakamura H
    Transplant Proc; 1992 Aug; 24(4):1409-10. PubMed ID: 1496600
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac allograft tolerance induction with limited immunosuppression.
    Cohen DS; Fisher RA; Tarry WC; Tawes JW
    J Surg Res; 1996 Mar; 61(2):355-60. PubMed ID: 8656608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of donor specific transfusion and rapamycin prolongs cardiac allograft survival in mice.
    Wu K; Xiang F; Yuan J; Zeng Z; Zhou H; Chang S; Chen ZK
    Transplant Proc; 2008 Dec; 40(10):3699-701. PubMed ID: 19100468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretransplant cytotoxic conditioning produces effects consistent with clonal deletion mechanisms.
    Zheng TL; Johnson CP; Sutherland DE
    J Surg Res; 1987 May; 42(5):498-502. PubMed ID: 3295388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of transfusion with donor-specific peripheral lymphocytes, whole blood or erythrocytes on cardiac allograft survival in cyclosporine-treated rats.
    Ahmed SM; Baslaim G; Eshelby D; Guttmann RD; Tchervenkov JI
    Transplantation; 1994 Feb; 57(4):634-7. PubMed ID: 8116053
    [No Abstract]   [Full Text] [Related]  

  • 29. Donor-specific transfusions add only in a minor degree to the effect of cyclosporine A.
    Stevens DW; Jensen CP; Jensen RM; Stevens LE
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1091-3. PubMed ID: 3291216
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation.
    Antoniou EA; Drayson M; Howie AJ; McMaster P; D'Silva M
    Transplant Proc; 1999 Nov; 31(7):2796-8. PubMed ID: 10578296
    [No Abstract]   [Full Text] [Related]  

  • 31. In-vitro mechanisms responsible for prolonged rat cardiac allograft survival induced by ultraviolet irradiated donor-specific blood and cyclosporine.
    Oluwole SF; Chabot J; Pepino P; Reemtsma K; Hardy MA
    Transplant Proc; 1987 Oct; 19(5):4331-3. PubMed ID: 2960059
    [No Abstract]   [Full Text] [Related]  

  • 32. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of antigen-specific tolerance: antigen form and injection route.
    Yoshimura N; Hamashima T; Oka T
    Transplant Proc; 1996 Jun; 28(3):1150-1. PubMed ID: 8658604
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolongation of cardiac allograft survival in rats following combination treatment with 2-chloro-2'-deoxyadenosine and cyclosporine: a novel immunosuppressive strategy.
    Nawrocki G; Grieb P; Górski A; Danielewicz R; Rowiński W
    Transplant Proc; 1996 Dec; 28(6):3538-9. PubMed ID: 8962374
    [No Abstract]   [Full Text] [Related]  

  • 35. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolongation of allograft survival in rat heterotopic heart transplantation by TLCK, a serine protease inhibitor.
    Morrissey PE; Gollin G; Brusett K; Marks WH
    Transplantation; 1994 Feb; 57(4):631-3. PubMed ID: 8116052
    [No Abstract]   [Full Text] [Related]  

  • 37. Donor-specific transfusions in renal transplantation in children. Effect of azathioprine plus transfusions.
    Friedman A; Deierhoi M; Chesney R; Sollinger H; Belzer F
    Transplantation; 1987 Jul; 44(1):159-61. PubMed ID: 3299916
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of azathioprine versus cyclosporine on kidney graft survival in transfused and nontransfused unmatched mongrel dogs.
    Finco DR; Rawlings CA; Crowell WA; Brown SA; Barsanti JA
    J Vet Intern Med; 1987; 1(2):61-6. PubMed ID: 3333409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
    Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.